These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 9812077)

  • 1. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy.
    Fattori R; Rocchi G; Celletti F; Bertaccini P; Rapezzi C; Gavelli G
    Am Heart J; 1998 Nov; 136(5):824-30. PubMed ID: 9812077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac amyloidosis mimicking the echocardiographic appearance of obstructive hypertrophic myopathy.
    Presti CF; Waller BF; Armstrong WF
    Chest; 1988 Apr; 93(4):881-3. PubMed ID: 3349849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
    Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
    Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].
    Fattori R; Rapezzi C; Castriota F; Magnani G; Bertaccini P; Galiè N; Magnani B; Gavelli G
    Radiol Med; 1994; 88(1-2):36-43. PubMed ID: 8066253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of identifying amyloid and hypertrophic cardiomyopathy with the use of computerized quantitative texture analysis of clinical echocardiographic data.
    Chandrasekaran K; Aylward PE; Fleagle SR; Burns TL; Seward JB; Tajik AJ; Collins SM; Skorton DJ
    J Am Coll Cardiol; 1989 Mar; 13(4):832-40. PubMed ID: 2926037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac amyloidosis mimicking hypertrophic cardiomyopathy.
    Hemmingson LO; Eriksson P
    Acta Med Scand; 1986; 219(4):421-3. PubMed ID: 3716885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall.
    Oki T; Tanaka H; Yamada H; Tabata T; Oishi Y; Ishimoto T; Nagase N; Shinohara H; Sakabe K; Fukuda N
    Am J Cardiol; 2004 Apr; 93(7):864-9. PubMed ID: 15050490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of echocardiography in differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy].
    Puchala M
    Vnitr Lek; 1989 Jul; 35(7):639-44. PubMed ID: 2800368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study.
    Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yamanaka S; Iiyama T; Kumagai N; Furuno T; Sugiura T; Kitaoka H
    BMC Cardiovasc Disord; 2015 Jun; 15():53. PubMed ID: 26077897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
    Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
    Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
    Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
    Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
    Weston LT; Raybuck BD; Robinowitz M; Brinker JA; Oetgen WJ
    Cathet Cardiovasc Diagn; 1986; 12(3):176-81. PubMed ID: 3015411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular dysplasia as a generalized cardiomyopathy? findings on magnetic resonance imaging.
    Molinari G; Sardanelli F; Gaita F; Ottonello C; Richiardi E; Parodi RC; Masperone MA; Caponnetto S
    Eur Heart J; 1995 Nov; 16(11):1619-24. PubMed ID: 8881856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of magnetic resonance in studying hypertrophic cardiomyopathy: the echocardiographic correlations and clinical implications].
    Rapezzi C; Fattori R; Castriota F; Passarelli P; Magnani G; Galiè N; Ferlito M; Bertaccini P; Branzi A; Gavelli G
    Cardiologia; 1994 Jan; 39(1):7-15. PubMed ID: 8020058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A special case of hypertrophic cardiomyopathy with a differential diagnosis of isolated cardiac amyloidosis or junctophilin type 2 associated cardiomyopathy.
    De Bruijn S; Galloo X; De Keulenaer G; Prihadi EA; Brands C; Helbert M
    Acta Clin Belg; 2021 Apr; 76(2):136-143. PubMed ID: 31478477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia.
    Roberts WC; Ferrans VJ
    Hum Pathol; 1975 May; 6(3):287-342. PubMed ID: 124302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy and symptomatic conduction system disease in cardiac amyloidosis.
    Garg P; Gupta R; Hsi DH; Sheils LA; DiSalle MR; Woodlock TJ
    South Med J; 2006 Dec; 99(12):1390-2. PubMed ID: 17233198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.
    Nam BD; Kim SM; Jung HN; Kim Y; Choe YH
    Int J Cardiovasc Imaging; 2018 Nov; 34(11):1769-1777. PubMed ID: 29846837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.